ATTENTION ALL CUSTOMERS:
Due to a recent change in our pharmacy software system, the process for submitting refill requests online has now changed.
Our previous mobile app and your current login credentials will no longer work.
Please click the Patient Portal tab to begin the new process.
Thank you for your patience during this transition.

New Patients Please Call 859-495-3972 or complete this New Patient Form
272 West Pike Street, Covington, KY 41011 | Phone: (859) 261-1313 | Fax: (859) 655-3042 | Mon - Fri: 9am - 6pm | Sat: 9am - 2pm | Sun: Closed
Slide background Welcome to Blank's Pharmacy Serving our neighbors since 1933
Your health is our priority.

We take our role in your health very seriously. Come in today to see how we can help.

Download iPhone App Download Android App Text Me A Link

Serving our neighbors since 1933

Recent health news and videos.

Staying informed is also a great way to stay healthy. Keep up-to-date with all the latest health news here.

10 Dec

New Study Links Agent Orange to Rare Blood Cancer in Vietnam Vets

A landmark study finds Vietnam veterans exposed to Agent Orange face a significantly higher risk of developing myelodysplastic syndrome. Researchers hope this finding helps veterans get the health and disability benefits they’ve been denied for 50 years.

09 Dec

Do GLP-1 Drugs Affect Cancer Risk? New Study Says Probably Not

A review of 48 clinical trials on GLP-1 safety suggests the popular meds probably have little to no effect on cancer risk.

08 Dec

Two New Studies Find Strong Link Between Epilepsy and Depression

Depression not only makes epilepsy harder to treat but may also raise the risk of developing it, new research finds.

GLP-1 Medications Show Little Effect on Cancer, Study Shows

I. Edwards HealthDay Reporter December 10, 2025

GLP-1 Medications Show Little Effect on Cancer, Study Shows

A new study suggests popular GLP-1 drugs, like Ozempic and Zepbound, may not lower cancer risk as some had hoped.

Researchers analyzed 48 randomized trials including 94,245 adults who were overweight, obese or had type 2 diabetes. More than 51,000 people took a GLP-1 drug, and nearly 43,000 received a placebo and were followed for about 70... Full Page

Opioid Use Linked to Higher Risk of C. Diff Infection, Study Finds

I. Edwards HealthDay Reporter December 10, 2025

Opioid Use Linked to Higher Risk of C. Diff Infection, Study Finds

Taking opioids may make some patients more likely to develop a dangerous infection, new research suggests.

The infection is called Clostridioides difficile, or C. diff. It affects the colon and can spread easily, especially in hospitals and nursing homes. The illness can cause severe diarrhea, stomach pain, nausea and vom... Full Page

CDC Delays Annual Abortion Report Amid Internal Turmoil

I. Edwards HealthDay Reporter December 10, 2025

CDC Delays Annual Abortion Report Amid Internal Turmoil

For decades, the U.S. Centers for Disease Control and Prevention (CDC) has released a yearly report tracking abortion trends across the country.

But this year’s report has been delayed until spring, and the agency says internal changes and staffing issues are to blame.

The report is usually released in late November and include... Full Page

Many Young Americans Still Smoking Tobacco and Cannabis, Study Shows

I. Edwards HealthDay Reporter December 10, 2025

Many Young Americans Still Smoking Tobacco and Cannabis, Study Shows

Many young Americans are still smoking nicotine, tobacco or cannabis, even as edibles and vapes continue to grow in popularity.

A University of Michigan study looked at how 12- to 34-year-olds are using these substances today. Researchers examined data from 8,722 individuals who had used at least one of these products within the last 30 da... Full Page

AI Can Improve Epilepsy Treatment, Experts Argue

Dennis Thompson HealthDay Reporter December 10, 2025

AI Can Improve Epilepsy Treatment, Experts Argue

Artificial intelligence (AI) can help improve treatment of epilepsy by connecting the dots in complex cases, a new study says.

AI helped identify patients with drug-resistant epilepsy who might benefit from surgery, and it highlighted missing tests and evaluations that could better guide patients’ care, researchers reported in Atlant... Full Page

U.S. ERs Are Failing Sickle Cell Patients In Pain, Study Says

Dennis Thompson HealthDay Reporter December 10, 2025

U.S. ERs Are Failing Sickle Cell Patients In Pain, Study Says

U.S. emergency rooms are failing patients in severe pain from a sickle cell disease crisis, a new study says.

Only 1 in 3 patients in an ER for sickle cell crisis receive opioid painkillers within the first hour as treatment guidelines recommend, researchers reported Saturday in Orlando at an American Society of Hematology meeting.

A... Full Page

HealthDay
Health News is provided as a service to Blank's Pharmacy site users by HealthDay. Blank's Pharmacy nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.
Copyright © 2025 HealthDay All Rights Reserved.

Our Affiliations

AmeriSource
Good Neighbor Pharmacy
National Community Pharmacists Association